| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f7c41518ab2564e700927ab7bf2ff79 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
| filingDate |
2014-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cef7453dc9feac6f7aa7fdce247fbead
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db23e2eff320885d8ecf33b69aa6d238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d3cf46e62e8d768a762883a2518444d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_596e91817edba2c66f6f07323a268f33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd9e53ef573b5f6bac35e6dc21347ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14972d2c599a3b7d1ee82d4d8ee8c9b3 |
| publicationDate |
2016-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2014377142-A1 |
| titleOfInvention |
Trail membrane-penetrating peptide-like mutant, method of preparing same, and use thereof |
| abstract |
A TRAIL mutant is provided. The mutant is a truncation of an amino acid sequence of positions 114-281 of an extracellular portion of a wild-type TRAIL protein, wherein the amino acids at positions 114-121 of said truncation are mutated into eight arginines. The TRAIL mutant may be used to treat tumors. |
| priorityDate |
2013-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |